Your browser doesn't support javascript.
loading
Patterns of healthcare utilization in patients with generalized anxiety disorder in general practice in Germany
Edelsberg, John; Oster, Gerry; Berger, Ariel; Dukes, Ellen; Morlock, Robert; Wittchen, Hans-Ulrich.
Affiliation
  • Edelsberg, John; Inc. (PAI). Policy Analysis. USA
  • Oster, Gerry; Inc. (PAI). Policy Analysis. USA
  • Berger, Ariel; Inc. (PAI). Policy Analysis. USA
  • Dukes, Ellen; Pfizer Inc. USA
  • Morlock, Robert; Pfizer Inc. USA
  • Wittchen, Hans-Ulrich; Technische Universitaet Dresden. Institute of Clinical Psychology and Psychotherapy. Dresden. Germany
Eur. j. psychiatry ; 23(2): 90-100, abr.-jun. 2009. ilus, tab
Article in English | IBECS | ID: ibc-85511
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Background and

Objectives:

To describe patterns of healthcare utilization among patients with generalized anxiety disorder (GAD) in general practitioner (GP) settings in Germany.

Methods:

Using a large computerized database with information from GP practices across Germany, we identified all patients, aged > 18 years, with diagnoses of, or prescriptions for, GAD (ICD-10 diagnosis code F41.1) between October 1, 2003 and September 30, 2004 («GAD patients»). We also constituted an age- and sex-matched comparison group, consisting of randomly selected patients without any GP encounters or prescriptions for anxiety or depression (a common comorbidity in GAD) during the same period. GAD patients were then compared to those in the matched comparison group over the one-year study period.

Results:

The study sample consisted of 3340 GAD patients and an equal number of matched comparators. Mean age was 53.2 years; 66.3% were women. Over the 12-month study period, GAD patients were more likely than matched comparators to have encounters for various comorbidities, including sleep disorders (odds ratio [OR] = 6.75 [95% CI = 5.31, 8.57]), substance abuse disorders (3.91 [2.89, 5.28]), and digestive system disorders (2.62 [2.36, 2.91]) (all p < 0.01). GAD patients averaged 5.6 more GP encounters (10.5 [SD = 8.8] vs 4.9 [5.7] for comparison group) and 1.4 more specialist referrals (2.3 [2.9] vs 0.9 [1.7]) (both p < 0.01). Only 58.3% of GAD patients received some type of psychotropic medication (i.e., benzodiazepines, antidepressants, and/or sedatives/hypnotics).

Conclusions:

Patients with GAD in GP practices in Germany have more clinically recognized comorbidities and higher levels of healthcare utilization than patients without anxiety or depression (AU)
Subject(s)
Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Anxiety Disorders / Primary Health Care Aspects: Implementation research Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur. j. psychiatry Year: 2009 Document type: Article Institution/Affiliation country: Inc. (PAI)/USA / Pfizer Inc/USA / Technische Universitaet Dresden/Germany
Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Anxiety Disorders / Primary Health Care Aspects: Implementation research Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur. j. psychiatry Year: 2009 Document type: Article Institution/Affiliation country: Inc. (PAI)/USA / Pfizer Inc/USA / Technische Universitaet Dresden/Germany
...